These signaling cascades, including MAPK, JAK-STAT, and EGFR/PI3K/Akt/mTOR, orchestrate key oncogenic processes, while dysregulation in pathways like Wnt/β-catenin, VEGF/VEGFR, and NF-κB promotes tumor progression and angiogenesis. This evidence concerns the gene EGFR and neoplasm.